Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis

Objectives: Cancer development and/or progression can be imputed to telomere shortening or lengthening. The cur- rent research was planned to assess the relation between leucocyte telomere length (LTL) and nasopharyngeal carci- noma (NPC) development, and to evaluate the association between this biomarker and patients' clinical outcomes, mainly response to chemo-radiotherapy, survival and EBV-DNA load. Methods: Leucocyte telomere length was measured using a singleplex quantitative polymerase chain reaction (qPCR) method in 104 NPC patients and 52 healthy controls. The association between LTL and NPC development was assessed using a Khi-deux test. Odds ratios (ORs) and 95% confidence intervals (CI) were calculated by conditional logistic re- gression to evaluate the relationship LTL and patient’s characteristics. The correlation between LTL and 4-years patient’s survival outcomes was assessed by Kaplan–Meier and Cox-regression analyses. Results: Data analysis revealed a significant association between LTL and risk of NPC development (p<0.0001). LTL was also significantly associated with gender (p=0.003), cigarette smoking (p=0.02) and pre-EBV-DNA load (p=0.017) in NPC. However, no significant association was obtained between LTL and age, alcohol consumption, TNM classification, disease stage, response to chemo-radiotherapy and survival outcomes of NPC patients (p>0.05). Conclusion: The study finding highlighted the close association between LTL and NPC development and showed a sig- nificant association with gender, cigarette smoking and pre-EBV-DNA load, suggesting that LTL could be a promising biomarker for better management of NPC in Morocco. Nevertheless, more studies are needed to highlight the value of LTL as a biomarker for the prediction of the response to treatment and prognosis of NPC.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Lan M, Chen C, Huang Y, Mao M, Han F, Liao J, et al. Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era. Oncotarget 2016;7:46242–52.
2. Peng H, Guo R, Chen L, Zhang Y, Li WF, Mao YP, et al. Prognostic impact of plasma epstein-barr virus DNA in patients with na- sopharyngeal carcinoma treated using intensity-modulated radiation therapy. Sci Rep 2016;6:22000.
3. Benider A, Harif M, Karkouri M, Quessar A, Sahraoui S, Sqalli S, et al. Registre des cancers de la région du Grand Casablanca pour la période 2013–2017. Lalla Salma Foundation 2017:1– 180.
4. Lourembam DS, Singh AR, Sharma TD, Singh TS, Singh TR, Singh LS. Evaluation of risk factors for nasopharyngeal car - cinoma in a high-risk area of India, the northeastern region. Asian Pac J Cancer Prev 2015;16:4927–35.
5. Ko JMY, Tsang KHK, Dai W, Choi SSA, Leong MML, Ngan RKC, et al. Leukocyte telomere length associates with nasopharyn- geal carcinoma risk and survival in Hong Kong Chinese: Role of LTL for NPC risk and survival of Stage IV patients. Int J Can- cer 2018;143:2289–98.
6. Adham M, Greijer AE, Verkuijlen SA, Juwana H, Fleig S, Rach- madi L, et al. Epstein-Barr virus DNA load in nasopharyn- geal brushings and whole blood in nasopharyngeal carci- noma patients before and after treatment. Clin Cancer Res 2013;19:2175–86.
7. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210–9.
8. Castilho RM, Squarize CH, Almeida LO. Epigenetic modifica- tions and head and neck cancer: implications for tumor pro- gression and resistance to therapy. Int J Mol Sci 2017;18:1506.
9. Wei G, Zhu J, Hu HB, Liu JQ. Circular RNAs: Promising biomark- ers for cancer diagnosis and prognosis. Gene 2021;771:145365.
10. Maciejowski J, de Lange T. Telomeres in cancer: tumour suppression and genome instability. Nat Rev Mol Cell Biol 2017;18:175–86.
11. Zhang ZX, Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou T. Sub - telomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopha- ryngeal carcinoma cell lines. Cancer Biother Radiopharm 2014;29:289–94.
12. Antwi SO, Petersen GM. Leukocyte telomere length and pan- creatic cancer risk: updated epidemiologic review. Pancreas 2018;47:265–71.
13. Blackburn EH. Telomere states and cell fates. Nature 2000;408:53–6.
14. Mu J, Wei LX. Telomere and telomerase in oncology. Cell Res 2002;12:1–7.
15. Wen Z, Xiao JY, Guo MH. Telomere shortening in the patho- genesis of nasopharyngeal carcinoma. Di Yi Jun Yi Da Xue Xue Bao 2002;22:329–30.
16. Luu HN, Qi M, Wang R, Adams-Haduch J, Miljkovic I, Opresko PL, et al. Association between leukocyte telomere length and colorectal cancer risk in the Singapore Chinese health study. Clin Transl Gastroenterol 2019;10:e00043.
17. Sun Y, Zhang L, Zhao L, Wu X, Gu J. Association of leuko - cyte telomere length in peripheral blood leukocytes with endometrial cancer risk in Caucasian Americans. CARCIN 2015;36:1327–32.
18. Xu J, Chang WS, Tsai CW, Bau DT, Xu Y, Davis JW, et al. Leuko- cyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients. eBioMedicine. Available at : https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(19)30831-X/fulltext. Accessed Aug 27, 2022.
19. Yuan JM, Beckman KB, Wang R, Bull C, Adams-Haduch J, Huang JY, et al. Leukocyte telomere length in relation to risk of lung adenocarcinoma incidence: Findings from the Singapore Chinese Health Study: Telomere length and lung cancer. Int J Cancer 2018;142:2234–43.
20. Gihbid A, Benzeid R, Faouzi A, El Alami I, Tawfiq N, Benchak- roun N, et al. The dynamic change in plasma epstein–barr virus DNA load over a long-term follow-up period predicts prognosis in nasopharyngeal carcinoma. Viruses 2022;15:66.
21. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:47e–47.
22. Alsafadi N, Alqarni MS, Attar M, Mgarry R, Bokhari A. Nasopha- ryngeal cancer: prevalence, outcome, and impact on health- related quality of life at Princess Norah Oncology Center, Jed- dah, Saudi Arabia. Cureus 2020;12:e8199.
23. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16:2649- 55.
24. Zheng X, Wezel F, Azoitei A, Meessen S, Wang W, Najjar G, et al. Shorter leukocyte telomere length is associated with worse survival of patients with bladder cancer and renal cell carci- noma. Cancers 2021;13:3774.
25. Alves-Paiva RM, Gutierrez-Rodrigues F, Pereira-Martins DA, Figueiredo DLA, Clé DV, Conti-Freitas LC, et al. Short telomere length in peripheral blood leukocytes in head and neck can- cer: Findings in a Brazilian cohort. Head Neck 2019;41:672–7.
26. Alhareeri AA, Archer KJ, Fu H, Lyon DE, Elswick RK, Kelly DL, et al. Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cogni- tive domain measures: a longitudinal study. Breast Cancer Res 2020;22:137.
27. Astuti Y, Wardhana A, Watkins J, Wulaningsih W. Cigarette smoking and telomere length: A systematic review of 84 stud- ies and meta-analysis. Environmental Research 2017;158:480– 9.
28. Assani G, Xiong Y, Zhou F, Zhou Y. Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells ra- diosensitivity. Oncotarget 2018;9:35008–25.
29. Rivera S, Keryer C, Busson P, Maingon P. Nasopharyngeal carci- nomas: from biology to clinic. Cancer Radiother 2005;9:55–68.
30. Slijepcevic P. Is there a link between telomere maintenance and radiosensitivity? Radiat Res 2004;161:82–6.
31. Lu L, Zhang C, Zhu G, Irwin M, Risch H, Menato G, et al. Telom- erase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease out - come. Breast Cancer Res 2011;13:R56.
32. Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, et al. Telomere length and survival in primary cutaneous melanoma patients. Sci Rep 2018;8:10947.
33. Richardo T, Prattapong P, Ngernsombat C, Wisetyaningsih N, Iizasa H, Yoshiyama H, et al. Epstein-barr virus mediated sig- naling in nasopharyngeal carcinoma carcinogenesis. Cancers (Basel) 2020;12:2441.
34. Kamranvar SA, Chen X, Masucci MG. Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein–Barr virus. Oncogene 2013;32:5522–30.

APA	ALAMI I, amina g, AZZOUZI M, Charoute H, BRAHIM S, TAWFIQ N, Benchakroun N, BENIDER A, Benani a, El Mzibri M, BELGHMI K, Khyatti M, chaoui i (2023). Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. , 135 - 142. 10.14744/ejmo.2023.19019
Chicago	ALAMI Imane El,amina gihbid,AZZOUZI Meryem El,Charoute Hicham,BRAHIM Selma Mohamed,TAWFIQ Nezha,Benchakroun Nadia,BENIDER Abdellatif,Benani abdelouaheb,El Mzibri Mohammed,BELGHMI Khalid,Khyatti Meriem,chaoui imane Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. (2023): 135 - 142. 10.14744/ejmo.2023.19019
MLA	ALAMI Imane El,amina gihbid,AZZOUZI Meryem El,Charoute Hicham,BRAHIM Selma Mohamed,TAWFIQ Nezha,Benchakroun Nadia,BENIDER Abdellatif,Benani abdelouaheb,El Mzibri Mohammed,BELGHMI Khalid,Khyatti Meriem,chaoui imane Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. , 2023, ss.135 - 142. 10.14744/ejmo.2023.19019
AMA	ALAMI I,amina g,AZZOUZI M,Charoute H,BRAHIM S,TAWFIQ N,Benchakroun N,BENIDER A,Benani a,El Mzibri M,BELGHMI K,Khyatti M,chaoui i Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. . 2023; 135 - 142. 10.14744/ejmo.2023.19019
Vancouver	ALAMI I,amina g,AZZOUZI M,Charoute H,BRAHIM S,TAWFIQ N,Benchakroun N,BENIDER A,Benani a,El Mzibri M,BELGHMI K,Khyatti M,chaoui i Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. . 2023; 135 - 142. 10.14744/ejmo.2023.19019
IEEE	ALAMI I,amina g,AZZOUZI M,Charoute H,BRAHIM S,TAWFIQ N,Benchakroun N,BENIDER A,Benani a,El Mzibri M,BELGHMI K,Khyatti M,chaoui i "Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis." , ss.135 - 142, 2023. 10.14744/ejmo.2023.19019
ISNAD	ALAMI, Imane El vd. "Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis". (2023), 135-142. https://doi.org/10.14744/ejmo.2023.19019

APA	ALAMI I, amina g, AZZOUZI M, Charoute H, BRAHIM S, TAWFIQ N, Benchakroun N, BENIDER A, Benani a, El Mzibri M, BELGHMI K, Khyatti M, chaoui i (2023). Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. Eurasian Journal of Medicine and Oncology, 7(2), 135 - 142. 10.14744/ejmo.2023.19019
Chicago	ALAMI Imane El,amina gihbid,AZZOUZI Meryem El,Charoute Hicham,BRAHIM Selma Mohamed,TAWFIQ Nezha,Benchakroun Nadia,BENIDER Abdellatif,Benani abdelouaheb,El Mzibri Mohammed,BELGHMI Khalid,Khyatti Meriem,chaoui imane Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. Eurasian Journal of Medicine and Oncology 7, no.2 (2023): 135 - 142. 10.14744/ejmo.2023.19019
MLA	ALAMI Imane El,amina gihbid,AZZOUZI Meryem El,Charoute Hicham,BRAHIM Selma Mohamed,TAWFIQ Nezha,Benchakroun Nadia,BENIDER Abdellatif,Benani abdelouaheb,El Mzibri Mohammed,BELGHMI Khalid,Khyatti Meriem,chaoui imane Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. Eurasian Journal of Medicine and Oncology, vol.7, no.2, 2023, ss.135 - 142. 10.14744/ejmo.2023.19019
AMA	ALAMI I,amina g,AZZOUZI M,Charoute H,BRAHIM S,TAWFIQ N,Benchakroun N,BENIDER A,Benani a,El Mzibri M,BELGHMI K,Khyatti M,chaoui i Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. Eurasian Journal of Medicine and Oncology. 2023; 7(2): 135 - 142. 10.14744/ejmo.2023.19019
Vancouver	ALAMI I,amina g,AZZOUZI M,Charoute H,BRAHIM S,TAWFIQ N,Benchakroun N,BENIDER A,Benani a,El Mzibri M,BELGHMI K,Khyatti M,chaoui i Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis. Eurasian Journal of Medicine and Oncology. 2023; 7(2): 135 - 142. 10.14744/ejmo.2023.19019
IEEE	ALAMI I,amina g,AZZOUZI M,Charoute H,BRAHIM S,TAWFIQ N,Benchakroun N,BENIDER A,Benani a,El Mzibri M,BELGHMI K,Khyatti M,chaoui i "Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis." Eurasian Journal of Medicine and Oncology, 7, ss.135 - 142, 2023. 10.14744/ejmo.2023.19019
ISNAD	ALAMI, Imane El vd. "Association of Leucocyte Telomere Length with Nasopharyngeal Carcinoma Risk and Prognosis". Eurasian Journal of Medicine and Oncology 7/2 (2023), 135-142. https://doi.org/10.14744/ejmo.2023.19019